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Background: Post-fermented tea has been used for the prevention of metabolic syndrome in Western China.
Present study reports the biochemical mechanism of lipid-lowering effects of Jing-wei fu tea (JWFT), a variety
of post-fermented tea on high-fat diet-induced hyperglycemia and obesity in rats.
Methods: Aqueous extract of JWFT was prepared by putting them in boiling water, and then concentrated under
reduced pressure. The major compounds of JWFT were determined by high performance liquid chromatography
(HPLC). High-fat diet fed rats were orally administered different doses of JWFT aqueous extract (0.5, 1.0 and 2.0 g/kg)
for four weeks. At the end of this experiment, hepatic lipids, serum leptin and lipids levels were determined using
enzyme-linked immunosorbent assay (ELISA). The hepatic fatty acid composition was analyzed using gas
chromatography mass (GC-MS). The relative expression of lipids metabolism genes was analyzed using reverse
transcriptase-polymerase chain reaction (RT-PCR).
Results: The results showed that JWFT inhibited the increase in the body weight, abdominal adipose weight, serum
lipids and hepatic lipids, and decreased serum leptin levels of high-fat diet fed rats. JWFT normalized hepatic fatty acid
composition of hyperlipidemia rats by up-regulating hepatic acetyl-CoA carboxylase (ACC), stearoyl-CoA desaturase 1
(SCD1) and fatty acid synthase (FAS) gene expression, and down-regulating carnitine palmitoyl transferase-1 (CPT1).
Furthermore, the results showed that JWFT inhibited the absorption of lipids.
Conclusion: JWFT could mitigate the obesity-induced hepatic steatosis by regulating hepatic lipogenesis and lipolysis.
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Obesity is a balance disruption of energy intake and ex-
penditure [1]. As a typical symptom of metabolic syn-
drome, hepatic steatosis was usually induced by high-fat
and high carbohydrate diet [2]. Liver is the main organ for
lipid uptake, de novo synthesis and fatty acid lipolysis [3].
Some lipogensis and lipolysis enzymes have been known
to be involved in the lipids synthesis and metabolism. For
example, acetyl-CoA carboxylase (ACC) converts the
acetyl-CoA to malonyl-CoA, which is the direct carbon* Correspondence: xcwan@ahau.edu.cn
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unless otherwise stated.donor for de novo synthesis of fatty acid. Fatty acid
synthase (FAS) organizes the structural skeleton of
fatty acid with malonyl-CoA. Stearoyl-CoA desaturase 1
(SCD1) is a critical rate-limiting enzyme of de novo
synthesis of monounsaturated fatty acids (MUFAs) [4].
Furthermore, increase in the carnitine palmitoyltransfer-
ase 1 (CPT1) substantially reduced the hepatic triglycer-
ides level because it increased the fatty acid oxidation [5].
While the deficiency of SCD1 increased the oxidation of
fatty acid, insulin sensitivity and resistance to diet-induced
obesity and liver steatosis [6].
Many traditional herbal materials have attracted much
attention because their various health benefits [7,8]. There
has been a very long history of tea consumption astd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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of polyphenols and caffeine. Its biological activities have
been widely studied with respect to cancer prevention,
anti-inflammatory, anti-hyperlipidemia and antimicrobial
effects [9,10]. Recently, post-fermented teas including pu-
erh tea and fuzhuan brick tea have been reported with
beneficial efficacy for metabolic syndrome in clinical inter-
vention trials and animal models [11]. For many years,
catechins and their gallate esters were widely reported as
the main active compounds of green tea for anti-cancer
and anti-obesity. In addition, (−)-epigallocatechin gallate
(EGCG) showed the effects of inhibiting lipids absorption
and synthesis [12]. But after post-fermentation, these com-
pounds were highly decreased compared with unfermented
tea. Therefore, it was suggested the catechins’ metabolite
formed in post-fermentation may contribute to the health
benefits of post-fermented tea [13].
“Fu” tea is a kind of post-fermented tea according to
the classification of processing method. Its history could
be dated back to the Ming Dynasty during 1500 A.D.
[14]. Jing-wei fu tea (JWFT) is made of the mature
leaves of Camellia sinensis by undergoing an intensified
fermentation of Eurotium cristatum [15]. The detailed
manufacture process of this tea could be described as
panning, rapid pile fermentation, rolling, drying, softening
with steam, piling, tea brick pressing, fungal fermentation,
and drying in order. The phase of “fungal fermentation” is
critical for typical aroma, taste and unique phytochemical
profiles.
The aim of this paper is to elucidate JWFT’s function of
regulating lipid metabolism and provide a novel under-
standing on lipid-lowering and anti-obesity activities of tea.Methods
Materials
The raw material of Jing-wei fu tea is the mature
large leaves of Camellia sinensis L. O. Kuntze. Jing-wei
fu tea (JWFT) was provided by Cang-shan Co, Ltd.
(Xianyang, Shaanxi, China) and formally identified by
Professor Xiaochun Wan. Tea leaves were collected
from tea plants (Camellia sinensis) in the Hanzhong dis-
trict of China. To process tea, the mature leaves were
dampened and fermented with the Eurotuim cristotium
under high humidity and temperature. All of the chemical
standards used in this study were with the purity of more
than 98%.Preparation and analysis of JWFT extract
Aqueous extract was prepared by boiling minced JWFT
powder with distilled water for 40 min at a ratio of 1:5
(w/v) three times. The filtered solution was combined
and concentrated at 60°C with rotary evaporator to
the required concentration, and then stored at 4°C. Theprocedures of sample preparation and HPLC analysis ref-
erenced published methods [16].Animals and treatment
Fifty male Sprague–Dawley (SD, 16 weeks old) rats were
purchased from the Animal Breeding and research cen-
ter of Anhui Medical University, China. This study was
approved by the Institutional Animal Care and Use
Committee of Anhui agricultural university and carried
out according to the guidelines of Care and Use of Animals
Laboratory. These rats were housed in an environmentally
controlled room (22 ± 2°C, 60 ± 5% relative humidity, and
12 hours light/dark cycle) and received food and water ad
libitum. At the beginning of study, the body weights
of rats were ranged from 160 to 200 g. After one week’s
acclimatization, rats were randomly divided into five
groups of 10 animals each. Four groups were fed high-fat
diet and the fifth group was fed normal control diet (NC).
One group of high-fat diet fed rats served as control group
(HFC) and was maintained on the high-fat diet alone until
the end of the study, while other three groups received
high-fat diet and daily oral administrations (20 ml/kg) of
JWFT extract for four weeks, at the dose of 0.5, 1.0 and
2.0 g/kg body weight, named as low (LJT), medium (MJT)
and high (HJT) dose of JWFT treatment group. After four
weeks’ treatment, the animals were fasted for 12 hours,
and then blood was taken from the femoral artery into
tubes and immediately centrifuged at 6000 rpm at 4°C
for 5 min. All the samples were stored at −80°C until
analyzed.Body weight, abdominal fat, serum lipids and leptin
analysis
Each rat’s body weight was recorded every week during
the whole experiment. At the last day, rats were fasted
for 12 h but free access to water, and then were anaesthe-
tized. Blood was drawn from the abdominal aorta and rats
were killed by exsanguinations. The intra-abdominal fat
(including epididymal, mesenteric, and retroperitoneal fat)
were removed and weighed. The body weights and
abdominal fat of treatment groups were statistically
compared with the HFC group. The levels of cholesterol,
triglycerides and high density lipoprotein-cholesterol
(HDL-C) were measured using ELISA methods with
an automatic analyzer (SPECTRA MAX 190, Molecu-
lar Devices, US). Low density lipoprotein-cholesterol
(LDL-C) levels were determined using the formula:
LDL-C = TC-(1/5TG + HDL-C) according to the pub-
lished methods [11].
The levels of serum leptin were determined using
automatic radioimmunoanalyzer according to the leptin
radioimmunoassy kit manufacturer’s (Beijing Northern
institute of biotechnology, Beijing, China) directions.
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Total liver lipid was extracted by homogenizing with
chloroform-methanol mixture (2:1, v/v) to a final dilu-
tion 20-fold the volume of the tissue sample according
to the published method [17]. The extraction was carried
out in a tissue tearor for three times. Pooled extract was
dried using a nitrogen evaporator. Hepatic total choles-
terol (TC) and triglycerides (TG) were determined by
ESLIA according to the manufacturer’s directions.
Preparation and analysis of fatty acid methyl ester
Fatty acid methyl ester (FAME) was prepared by a safe
rapid mean for methyl esterification with potassium
hydroxide-methanol as a reaction solution, and then was
extracted with hexane. 200 mg of lipids dissolved in
2 mL hexane and mixed well, then added 0.2 mL KOH-
methanol solution (2 M). These tubes were mixed by
vortex agitation for 30 sec and centrifuged at 5000 rpm
for 5 min. The supernatant containing FAME was dec-
anted and diluted with hexane, and then added 2 g sodium
sulfate anhydrous for overnight.
Gas chromatograph-mass spectrometer (GC-MS) ana-
lysis of fatty acids composition was performed using
Shimadzu GC-MSQP 2010S system (Tokyo, Japan)
equipped with a DB-5 capillary column (30 m × 0.32 mm
ID) (Agilent, USA). The injection volume was 1 μL and
split less. Helium was used as carrier gas and flow rate at
0.85 mL/min. The oven temperature program was from
150°C to 190°C at 18°C/min maintained for 1 min, 190°C
to 200°C at 0.5°C/min held for 5 min, 200°C to 230°C
at 2°C/min kept for 5 min. The injection and detector
(FID) temperatures were 250°C and 280°C respectively.
Mass detection was done with electric ionization at 1 keV
by using selected-ion monitoring/scan mode for masses in
the range of m/z at 50 to 600.
Analysis of the fecal lipids
In the 27th day, tea treatment and high-fat diet control
groups’ animals were fasted for 12 h. After that, tea
treatment groups were orally administered correspond-
ing dose of JWFT. After 30 min, equal lipids (containing
triglyceride and cholesterol) were given to each group
including high-fat diet control group, and then collected
the feces excreted of each rat from 0 to 24 h.
The feces were dried under reduced pressure at 40°C.
One gram of dry feces was accurately weighed, and ex-
tracted with chloroform and methanol (2:1). The fecal TG
and TC levels were determined using the kits from Nanjing
Jiancheng Bioengineering Institute (Nanjing, China).
RNA extraction and reverse transcriptase-polymerase
chain reaction (RT-PCR)
RNA was extracted from rat liver by homogenization in
RNAprep pure tissue kit (TianGen biotech CO. LTD,Beijing). Purity was determined using the 260/280 ratio on
a Nanodrop 2000 spectrophotometer (Thermo Scientific,
Wilmington, USA). Samples with a 260/280 ratio of 1.90
or greater were used for cDNA synthesis, using a cDNA
reverse transcription kit (Takra, 5 × Primescript RT
Master Mix) with Bio-Rad S1000™ Thermal cycler, pro-
grammed cycle of 37°C for 15 min, 85°C for 5 sec and 4°C
until storage at −80°C.
The primers for SCD1, ACC, CPT1, FAS and 18S house-
keeping gene were referenced the published references
[18,19]. Primers were ordered from Sangon Biotech
(Shanghai) Co., Ltd. RT-PCR was performed using
SYBR Green qPCR mastermix (Takra, SYBR® Permix
Ex Taq™II) on Bio-Rad CFX 96™ real-time PCR system.
The reaction volume was 20 μL. The program had an
initial incubation of 95°C for 30 sec, followed by 39 cycles
of 95°C for 5 sec and 60°C for 30 sec following 39 cycles, a
melt curve was produced by increasing the temperature
from 60 to 95°C at a rate of 0.5 per minute. Analysis of
data was performed by normalizing the threshold cycle
number (Δct) of the gene of interest to the Δct for the
housekeeping gene, 18S ribosomal RNA, using the 2-ΔΔct
method and expression HFC values relative to LJT, MJT,
HJT values and expressing in arbitrary units.
Statistical analysis
Results were expressed as means ± SEM, with the number
of determinations (n = 10) representing separate experi-
ment. Data were evaluated at a 0.05 level of significance
with one-way ANOVA with post-hoc testing by Fisher’s
protected least significant differences procedure.
Results
Polyphenol and caffeine contents of JWFT water extracts
As shown in Table 1, the contents of catechins-gallates
such as (−)-epigallocatechin gallate (EGCG), (−)-epicate-
chin gallate (ECG) and (−)-gallocatechin gallate (GCG)
were very low in JWFT. Different from ripened pu-erh
tea, the content of gallic acid was still very low [16].
These results indicated JWFT’s post-fermentation was
not the same as other Chinese dark teas which highly in-
creased the content of gallic acid.
Body weight, abdominal fat weight and serum lipids and
letpin levels
The hyperlipidemia rats of HFC group gained more
weight during the study than those fed a normal chow
diet (p < 0.01). Medium and high dose (1.0, 2.0 g/kg) of
JWFT extract exhibited a remarkable decrease in body
weight and abdominal fat weight compared with the
HFC (Figure 1, p < 0.05, 0.01). Serum TC and TG levels
of HFC group were consistently much higher than the NC
group after 28 days (p < 0.01). After four weeks’ treatment
of high dose of JWFT extract (2.0 g/Kg), serum TC, TG
Table 1 The contents of major polyphenols and caffeine of JWFT
Compound GA GC EGC C EC CA EGCG GCG ECG
Content (mg/g) 0.794 0.804 3.969 NDa 0.763 22.521 1.966 NDa 1.904
aND, not detected.
GA, gallic acid; GC, (−)-gallocatechin; EGC, (−)-epigallocatechin; C, (+)-catechin; EC, (−)-epicatechin; CA, caffeine; EGCG, (−)-epigallocatechin gallate; GCG,
(−)-gallocatechin gallate; ECG, (−)-epicatechin gallate.
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creased compared with HFC group (p < 0.05).
Hepatic total cholesterol and triglycerides levels
High-fat diet caused the elevation of hepatic total TG and
TC levels. JWFT treatment decreased the hepatic total TG
and TC levels. As shown in Figure 2, hepatic TC levels
were dose-dependently decreased by 15.93%, 17.24% and
29.56% at the doses of 0.5, 1.0 and 2.0 g/kg, respectively.
JWFT also significantly inhibited the increase in hepatic
total TG levels, and exhibited 42.34%, 55.49% reduction at
medium and high doses respectively. Although the low
dose of JWFT did not reduce TG level evidently, it had
27.57% reduction compared with HFC.
The above-mentioned results demonstrated that both
medium and high doses of JWFT can lower hepatic total
TG and TC levels.
Analysis of fatty acid and expression of CPT1, ACC, SCD1
and FAS of liver
Hepatic fatty acid composition was shown in the Table 2.
When rat was given high-fat diet, C18:0, C18:1n-9 and
C18:2 were significantly increased as previous reportFigure 1 The effects of JWFT on the lipids levels. (A) The average body
abdominal fat of rats after 4 weeks, (C) The levels of serum leptin of rats af
4 weeks, (E) The levels of serum total cholesterol of rats after 4 weeks, (F) T
compared with the HFC group.[20]. After the treatment of JWFT, the percentages of
C14:0, C15:0, C16:1n-7, C17:0, C18:1n-9 were markedly
(p < 0.05) decreased, only C18:0 significantly (p < 0.05)
elevated in HJT group compared with HFC.
The difference of fatty acid composition between HFC
and NC group (Figure 2) was profiled systematically by
lipidomics. Principal components analysis (PCA) of GC-
MS data sets showed that the HFC group was different
from NC. JWFT treatment group presented a similar
classification to NC group rather than HFC. It suggested
that the characteristics of whole fatty acids of JWFT rats
were similar to NC rats.
Hepatic stearoyl-CoA desaturase 1 (SCD1) activity could
be estimated from the C16:1/C16:0 or C18:1n-9/C18:0
ratios. As shown in Figure 3, SCD1 activity was dose-
dependently decreased in JWFT groups, but significantly
increased (p < 0.05) in HJT group compared with NC rats.
In order to verify the reliability of estimation, we further an-
alyzed the relative expression of SCD1, which was evidently
(p < 0.05, p < 0.01) down-regulated in MJT and HJT groups
with 74%, 96% reduction respectively (Figure 3). Fur-
thermore, the expression of other lipogenic genes, ACC
and FAS were also down-regulated in MJT and HJTweight of rats each group from 0 to 4 weeks, (B) The weights of
ter 4 weeks, (D) The levels of serum total triglycerides of rats after
he levels of serum LDL-C of rats after 4 weeks. *p < 0.05, **p < 0.01
Figure 2 The GC-MS profiles of lipids of liver. (A) The levels of total hepatic triglycerides of rats orally administered with JWFT, (B) The levels
of total hepatic cholesterol of rats orally administered with JWFT, (C) The GC-MS of fatty acids of liver of rats in HFC, NC and HJT group, (D) The
PCA analysis of GC-MS metabolomics of fatty acids. *p < 0.05, **p < 0.01, ***p < 0.001 compared with the HFC group.
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up-regulated in HJT, which indicated the increasing of
β-oxidation of fatty acids in liver (p < 0.05).
Fecal total cholesterol and triglycerides levels
At the 27th day, equivalent lipids (cholesterol and trigly-
cerdies) were given to HFC, LJT, MJT and HJT groups.
The feces excreted from 0 to 24th hour were analyzed.In all JWFT treatment groups (0.5, 1.0 and 2.0 g/kg), the
total fecal TC levels were highly increased compared
with the high fat group (p < 0.05, 0.01) as shown in
Table 3.
Discussion
Dysregulations of hepatic lipid synthesis have been as-
sociated with several metabolic diseases. We need a
Table 2 The proportional fatty acid composition of liver
Fatty acid NC HFC LJT MJT HJT
C14:0 0.31 ± 0.06 0.215 ± 0.04 0.2 ± 0.02 0.18 ± 0.03 0.1 ± 0.03*
C15:0 0.577 ± 0.06 0.124 ± 0.02 0.094 ± 0.02 0.04 ± 0.02 0.033 ± 0.01*
C16:0 25.17 ± 0.85 24.53 ± 0.49 25.38 ± 0.4 25.59 ± 0.53 23.76 ± 0.65
C16:1n-7 1.83 ± 0.28 0.665 ± 0.12 0.467 ± 0.06 0.429 ± 0.09 0.223 ± 0.05*
C17:0 1.4 ± 0.1 0.393 ± 0.05 0.349 ± 0.02 0.31 ± 0.02 0.241 ± 0.03*
C18:0 17.97 ± 0.67 21.62 ± 0.85 22.38 ± 0.67 23.46 ± 0.59 24.42 ± 0.88*
C18:1n-9 10.8 ± 0.83 15.08 ± 1.01 16.51 ± 1.13 16.14 ± 1.00 12.86 ± 0.73*
C18:1n-7 2.69 ± 0.11 1.75 ± 0.09 1.85 ± 0.34 2.09 ± 0.41 1.52 ± 0.06
C18:2n-6 12.73 ± 0.64 13.02 ± 0.65 13.86 ± 0.24 13.51 ± 0.25 13.43 ± 0.37
C18:3n-3 0.69 ± 0.08 0.76 ± 0.02 0.71 ± 0.05 0.72 ± 0.06 0.67 ± 0.09
C20:3n-3 0.38 ± 0.03 0.27 ± 0.02 0.19 ± 0.01 0.18 ± 0.01 0.23 ± 0.02
C20:3n-6 0.35 ± 0.04 0.18 ± 0.03 0.12 ± 0.02 0.11 ± 0.01 0.16 ± 0.03
C20:4n-6 13.91 ± 0.61 13.30 ± 0.73 12.11 ± 0.45 12.26 ± 0.32 13.41 ± 0.55
C20:5n-3 0.52 ± 0.06 0.32 ± 0.03 0.25 ± 0.02 0.21 ± 0.01 0.26 ± 0.02
C22:6n-3 2.63 ± 0.17 2.34 ± 0.11 1.95 ± 0.15 1.69 ± 0.06 2.70 ± 0.22
NC, normal chow group; HFC, high dose of fat chow group; LJT, low dose of Jing-wei fu tea group; MJT, medium dose of Jing-wei fu tea group; HJT, high dose of
Jing-wei fu tea group.
All data are presented as mean ± SEM, *Compared with HFC, *P < 0.05.
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regulation in disease process of metabolic syndrome [21].
For example, nonalcoholic fatty liver disease (NAFLD) is a
common disease characterized by excessive accumulation
of triglyceride in the liver. Excessive energy intake is an
important contributor to the increasing of NAFLD in
modern society [22]. In the present study, we intended to
investigate the changes related to lipid metabolism of liver
tissue induced by high-fat diet using a combined tran-
scriptomic and metabolomic approach [23]. Furthermore,
the variations of gene expression indicated the regulation
pathways of molecular pathogenesis of hepatic steatosis.
In view of the complexity of the hepatic steatosis, our
study adopted a strategy of metabolomics profiling for
investigating the hepatic fatty acids between normal andFigure 3 The effects of JWFT on expression of lipids metabolism gen
(C) The mRNA expression of hepatic lipogenic genes. *P < 0.05, **P < 0.01,hyperlipidemia rats. With PCA analysis of fatty acids com-
position, it showed that the normal rats were highly differ-
ent with the high fat induced rats.
After four weeks’ high fat diet feeding, the serum lipids
levels, hepatic lipids levels, abdominal fat and body
weight were significantly increased. In tea treatment
groups, JWFT had the ability to lower the serum lipids
(TC, TG and LDL-C). Intra-abdominal fat deposition is
a key component of obesity. Some studies indicated that
it was an indicator for type 2 diabetes and metabolic
syndrome [24]. JWFT had a potent effect on decreasing
intra-abdominal fat weight. The results also showed that
body weight and abdominal fat weight were positively
correlated with serum leptin levels. The serum leptin
levels of HFC group was higher than NC group, whilees. (A), The ratios of C16:1/C16:0, (B) The ratios of C18:1n-9/C18:0,
***P < 0.001 compared with the HFC group.
Table 3 The levels of total cholesterols and total triglycerides of feces
HFC LJT MJT HJT
TC (mmol/100 g) 11.14 ± 1.88 17.35 ± 1.32* 18.45 ± 2.56* 18.60 ± 1.29**
TG (mmol/100 g) 6.34 ± 1.00 6.74 ± 0.41 7.48 ± 078 8.63 ± 1.38
HFC, high dose of fat chow group; LJT, low dose of Jing-wei fu tea group; MJT, medium dose of Jing-wei fu tea group; HJT, high dose of Jing-wei fu tea group.
All data are presented as mean ± SEM, *Compared with HFC, *P < 0.05, **P < 0.01.
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supplementation.
The expression of microRNA of major enzymes in-
volved in de novo synthesis, such as SCD1, ACC and
FAS were all significantly decreased after high-fat diet,
while the expression of CPT1 was increased. After the
treatment of JWFT, total hepatic cholesterol and triglyc-
erides levels were also decreased markedly by JWFT
treatment, which suggested a potentiality on reversing
adiposis hepatica. Furthermore, high dose of JWFT can
change the fatty acid composition of high-fat fed rats’
liver. Most of saturated and monounsaturated fatty acids
percent-age were decreased significantly, such as C14:0,
C15:0, C16:1n-7, C17:0 and C18:1n-9. TheC16:1/C16:0
or C18:1n-9/C18:0 ratios may be adjusted by the hepatic
SCD1 activity [20]. The ratio of C16:1/C16:0 and C18:1n-
9/C18:0 had a notably reduction with high dose JWFT
treatment, meanwhile, the level of relative expression of
SCD1 was down-regulated considerably in MJT and HJT
group. So, it was reasonable that the accumulation of
SCD1 substrates (SFA, C16:0 or C18:0) and reduction of
products (MUFA, C16:1n-7 or C18:1n-9).
The increased fat accumulation in the liver of HFD
rats caused a down-regulation of lipogenic genes and the
up-regulation of genes involved in catabolism of free
fatty acids, possibly by a feedback mechanism. We found
that several enzymes, which have been known to be in-
volved in the de novo synthesis, were down-regulated
after the high-fat diet. Parallel down-regulation of SCD1
in our study at mRNA levels is consistent with poten-
tially reduced fatty acid composition in liver of NAFLD
[25]. Furthermore, the CPT1 was known to be involved
in β-oxidation of fatty acid was also up-regulated in the
HFLD-fed group. In four weeks’ experiment, the up-
regulation of β-oxidation genes and down-regulation
of de novo synthesis could be effective on serum
lipids if the experiment had been conducted for a longer
duration.
Conclusions
In conclusion, JWFT exhibited a potential anti-obesity
effects for high-fat diet induced mice, which may be medi-
ated by firstly inhibiting the absorption of lipids, secondly
strengthening the feedback regulation of expression of de
novo lipogenic genes, and up-regulating CPT1 expression
in the liver. Furthermore, the RT-PCR results also showedthat rats resisted the over uptake of lipids by down-
regulating the expression of lipogenic genes. It was sup-
posed that in a short treatment, the absorption of lipids
was firstly controlled, because the low dose of JWFT also
promoted the excretion of lipid in feces. In a long term,
the regulation of metabolism should be responsible for the
lipids control.
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